Enzon Pharmaceuticals Inc (ENZN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 197 | -186 | -519 | -504 | -291 |
| Income taxes - deferred | -36 | -202 | N/A | N/A | 0 |
| Accounts receivable | N/A | 28 | N/A | N/A | N/A |
| Other Working Capital | 9 | -271 | -270 | -343 | 79 |
| Other Operating Activity | 0 | -28 | 0 | 0 | 0 |
| Operating Cash Flow | $170 | $-659 | $-789 | $-847 | $-212 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Dividend Paid | -1,275 | N/A | N/A | N/A | N/A |
| Financing Cash Flow | $-1,275 | $N/A | $N/A | $N/A | $N/A |
| Beginning Cash Position | 46,982 | 47,641 | 47,641 | 47,641 | 47,641 |
| End Cash Position | 45,877 | 46,982 | 46,852 | 46,794 | 47,429 |
| Net Cash Flow | $-1,105 | $-659 | $-789 | $-847 | $-212 |
| Free Cash Flow | |||||
| Operating Cash Flow | 170 | -659 | -789 | -847 | -212 |
| Free Cash Flow | 170 | -659 | -789 | -847 | -212 |